Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,482,458
+$1,494,558 QoQ
Shares Held
17,812
+100.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$21,872,700
PutShares
270,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $13,138,022 across 6 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,482,458 | 17,812 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $987,900 | 8,900 | Shares | Sole | 2025-11-17 | |
| 2024-06-30 | $371,934 | 5,421 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $21,872,700 | 270,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $8,756,856 | 108,096 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $495,579 | 5,973 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $498,191 | 8,380 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $348,528 | 4,800 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $10,165,400 | 140,000 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $9,779,000 | 140,000 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $4,889,500 | 70,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $1,047,750 | 15,000 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $1,074,430 | 18,442 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $255,748 | 3,324 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||